# Survival and virulence of Acinetobacter baumannii in microbial mixtures

**Authors:** Azam F. Tayabali, Yasmine Dirieh, Emma Groulx, Nusaybah Elfarawi, Sabrina Di Fruscio, Kristina Melanson, Houman Moteshareie, Mustafa Al-Gafari, Martha Navarro, Stéphane Bernatchez, Zerihun Demissie, Valar Anoop

PMC · DOI: 10.1186/s12866-024-03471-6 · 2024-09-06

## TL;DR

This study examines how mixing Acinetobacter baumannii with other bacteria affects its survival and harmfulness, which is important for biotech product safety.

## Contribution

The study reveals how microbial mixtures can reduce the growth and virulence of Acinetobacter baumannii under various conditions.

## Key findings

- Acinetobacter baumannii thrives under diverse environmental stressors except ciprofloxacin.
- Growth of Acinetobacter baumannii is reduced when co-cultured with a microbial mixture.
- Cytotoxicity and cytokine levels are suppressed in the presence of the microbial mixture.

## Abstract

Acinetobacter species such as A. venetianus and A. guillouiae have been studied for various biotechnology applications, including bioremediation of recalcitrant and harmful environmental contaminants, as well as bioengineering of enzymes and diagnostic materials. Bacteria used in biotechnology are often combined with other microorganisms in mixtures to formulate efficacious commercial products. However, if the mixture contained a closely related Acinetobacter pathogen such as A. baumannii (Ab), it remains unclear whether the survival and virulence of Ab would be masked or augmented. This uncertainty poses a challenge in ensuring the safety of such biotechnology products, since Ab is one of the most significant pathogens for both hospital and community -acquired infections. This research aimed to investigate the growth and virulence of Ab within a mixture of 11 bacterial species formulated as a mock microbial mixture (MM). Growth challenges with environmental stressors (i.e., temperature, pH, sodium, iron, and antibiotics) revealed that Ab could thrive under diverse conditions except in the presence of ciprofloxacin. When cultured alone, Ab exhibited significantly more growth in the presence of almost all the environmental stressors than when it was co-incubated with the MM. During the exposure of A549 lung epithelial cells to the MM, Ab growth was stimulated compared to that in standard mammalian culture media. Cytotoxicity caused by Ab was suppressed in the presence of the MM. Lymphocytes were significantly reduced in mice exposed to Ab with or without MM via intravenous injection. The levels of the splenic cytokines IL-1α, IL-1β, MCP-1, and MIP-1α were significantly reduced 24 h after exposure to Ab + MM. This study demonstrated that the presence of the MM marginally but significantly reduced the growth and virulence of Ab, which has implications for the safety of mixtures of microorganisms for biotechnological applications. Furthermore, these findings expand our understanding of the virulence of Ab during host–pathogen interactions.

The online version contains supplementary material available at 10.1186/s12866-024-03471-6.

## Linked entities

- **Chemicals:** ciprofloxacin (PubChem CID 2764)
- **Species:** Acinetobacter venetianus (taxon 52133), Acinetobacter guillouiae (taxon 106649), Acinetobacter baumannii (taxon 470), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** hospital (MESH:D003428), Cytotoxicity (MESH:D064420), -acquired infections (MESH:D017714)
- **Chemicals:** ciprofloxacin (MESH:D002939), sodium (MESH:D012964), iron (MESH:D007501)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Acinetobacter guillouiae (species) [taxon 106649], Acinetobacter venetianus (species) [taxon 52133], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11378493/full.md

---
Source: https://tomesphere.com/paper/PMC11378493